Coelho Rogerio Vivaldi insider trades
Open-market stock purchases and sales by Coelho Rogerio Vivaldi, Director at Crinetics Pharmaceuticals, Inc, from SEC Form 4 filings since Jun 30, 2014.
Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +8%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 18, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 18, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 12, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold | $19.2K |
| Mar 12, 2026 | CRNX Crinetics Pharmaceuticals, Inc | Sold | $162K |
| Mar 6, 2026 | VTRS Viatris Inc | Bought (not open market) | — |
| Mar 6, 2026 | VTRS Viatris Inc | Bought (not open market) | — |
| Mar 6, 2026 | VTRS Viatris Inc | Bought (not open market) | — |
| Mar 6, 2026 | VTRS Viatris Inc | Bought (not open market) | — |
Companies traded
- CRNX Crinetics Pharmaceuticals, Inc: 1 buy, 2 sales, last Jun 18, 2026
- VTRS Viatris Inc: other filings, last Mar 6, 2026
- SGTX Sigilon Therapeutics, Inc: other filings, last Aug 11, 2023
- BIVV Bioverativ Inc: other filings, last Mar 8, 2018
- ONCE Spark Therapeutics, Inc: 1 buy, 7 sales, last Jul 15, 2016
- NERV Minerva Neurosciences, Inc: 1 buy, last Jul 1, 2014
Get free alerts when Coelho Rogerio Vivaldi files a new trade →